OP-ED: Coronavirus: How a Rational CDC Scientist Would

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
309
OP-ED: Coronavirus: How a Rational CDC Scientist Would Think, if One Existed

https://www.greenmedinfo.com/blog/op-ed-coron...ne-existed

OP-ED by Jon Rappoport

In a recent article, I explained why the diagnostic test for the coronavirus in a patient is worthless and unreliable. The implications of that fact are enormous.

Here, I want to make further comments on fake science.

A rational researcher, at the CDC, if one existed, would say, upon hearing of a possible outbreak in the city of Wuhan: "Let's see the proof that a new virus is responsible, is the causative agent."

What kind of proof would he be asking for?

First, he would want to know, "Do researchers there have an actual biological specimen of this new virus? Do they have the real thing?"

And if the answer came back yes, he would reply, "We're sending in one of our Wuhan people so he can confirm that."

But how would the confirmation work? You can't just lay a specimen of a virus on a table and shine a light on it. It's far too small to see.

There is a traditional method of observation. It's called an electron microscope photograph (an EM). Certain established procedures exist for obtaining an EM from a patient's tissue sample. The CDC scientist would want to make sure the Chinese scientists had carried out this process correctly.

He would say, "Let's have a look at the Chinese EM." He wants to confirm there are many identical particles of the new virus in the EM. Let's buck the odds and imagine he does confirm it. So far, so good.

But there is more. And here is where the rubber meets the road and the failure factor is very high. I need to back up a bit to explain.

When a clinical trial of a new drug is done (and here I'll make a gigantic leap and assume it's done correctly), is it carried out on one patient?

Is the result of giving the drug to a single patient then extrapolated to mean everyone will react the way this one person did? Of course not. That would be absurd. In a clinical trial, sooner or later, researchers are dealing with a large number of volunteers. A thousand or more.

So, in the case of a new coronavirus, in China, the rational CDC scientist would say: "I want to see electron microscope photographs derived from five hundred patients who have been provisionally diagnosed with the new disease."

I myself ask, where are these photographs? Where are the completely necessary photographs? Because the Chinese scientist would tell his CDC counterpart, "Oh, we didn't carry out the EM procedure on five hundred patients. We carried it out on one. Two. Maybe three. I'm not sure."

At which point, this fantasy rational CDC scientist would blow his stack. He would say, "You're declaring a new epidemic based on two or three photographs from two or three patients??"

Of course, I would need rock solid proof that, at the CDC, there is a rational scientist who would ask for EM pictures from five hundred patients, and explode if he couldn't find them because they were never done. Show me such a rational CDC scientist. Bring him forward. I want to interview him. I want to find out how he feels being ostracized by every other scientist at the CDC.

Consider this likely scenario---which explains why researchers only did the EMs on two or three of the patients. If someone actually performed the electron microscope work on 500 patients diagnosed with the new disease, he would find some indication, in the photographs, of a coronavirus in maybe nine patients.

At which point, in Wuhan, they would shrug and say, "Well, wow, that didn't work out. What a flop. Our hypothesis of a new disease based on a new coronavirus collapsed. We should have been able to see lots of the virus in the photos from ALL 500 patients, or at least the overwhelming percentage of the 500. And we didn't. Back to the drawing board. Let's see. What's the primary sign of the new disease? Pneumonia? Come to think of it, about 300,000 people in China die of pneumonia every year. How about we look at some studies on the air quality here in Wuhan? I think my colleague down the block has a pile of them. Let's walk over there. Anybody have a searchlight so we can see the street through the fog of pollution? Let me get my oxygen tank and breathing helmet."

And that would be the end of that.

Back in Atlanta, the rational CDC scientist would say to his colleagues, "That Chinese outbreak wasn't a virus. How about we spend the afternoon going through some of our own studies on vaccines? I know the fraud is rampant. Let's get it out in the open."

Sure. Happens every day over at the CDC.

Of course, I could be wrong. Maybe someone has done electron microscope photographs derived from 500 patients diagnosed with the new epidemic disease. LET'S SEE THE PHOTOS. SHOW THEM TO ME. We'll have a few non-conflicted experts analyze them.

Otherwise, don't talk about science. There is no science going on.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 214

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading
Q32 Bio Eyes New Horizons with Bempikibart's Potentials

Updated Category News Views 54

Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...

Continue Reading
MY DR NOW Expands: Seven-Day Clinics Open Everywhere

Updated Category News Views 29

Breaking The Mold Of Traditional Medicine MY DR NOW isn't here to play by the age-old rules. They're slinging open the doors to their newest family medicine clinics and kicking the old Monday-to-Friday scheduling straight to the curb. Every single day of the week, from 8 a.m. to 8 p.m., patients in Sunnyvale and Tucson are getting a dose of healthcare that's all about...

Continue Reading
DarioHealth Taps Palumbo to Drive Healthcare Evolution

Updated Category News Views 64

Strategic Leadership for an Evolving Market Prepare your portfolios, folks. DarioHealth Corp. (NASDAQ:DRIO) is gearing up to ride a seismic shift in healthcare. John R. Palumbo's appointment as Chairman of the Board marks a bold move as Dario looks to dominate the new convergence of consumer-directed and payer-funded healthcare. This isn't just a change of guard; it's a...

Continue Reading
Hyundai Pushes Hydrogen Boundaries at 2026 Expo

Updated Category News Views 105

A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...

Continue Reading
Greasezilla to Process 15M Gallons of FOG Yearly

Updated Category News Views 37

Greasezilla Steps Up for FOG Processing If there’s one thing that makes dealing with wastewater a greasy business, it’s FOG - fats, oils, and grease. It’s the stuff nightmares are made of for any utility trying to keep their pipes clear and their operations running smooth. Now, Greasezilla is stepping into the spotlight at one of the country's largest wastewater...

Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes

Updated Category News Views 100

Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...

Continue Reading
Camtek Hits Record Q3 Revenue; Strong Growth Ahead

Updated Category News Views 99

Camtek's Record Performance in Q3 2026 Diving straight into the numbers, Camtek (NASDAQ:CAMT) just posted a staggering $161.3 million in Q3 2026 revenues, marking a 21% jump from the previous quarter. Now, that kind of growth isn't just impressive; it's a wake-up call to any investor still snoozing on semiconductor stocks. They're looking at revenues of around $180...

Continue Reading
Sinch Partners with SpaceX's Super Intelligence Network

Updated Category News Views 101

Piecing Together the New Sinch and SpaceX Partnership Here's a juicy piece of tech news that might just tickle those investing antennas: Sinch AB's teaming up with the SpaceX Super Intelligence Network as a Marketplace Partner. Let's rip the Band-Aid off about why this development has investors riled and buzzing with expectation. Now, Sinch might not be the first company...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 28

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Welcomes New Leaders to Enhance Reputation Strategy

Updated Category News Views 128

Strengthening Strategic Leadership at FTI Consulting Recently, FTI Consulting, Inc. (NYSE: FCN) made headlines with the addition of two distinguished professionals to their Corporate Reputation and Public Affairs teams in Chicago. David Duschene and Tim Peters have been appointed as Senior Managing Directors within the firm’s Strategic Communications segment, marking a...

Continue Reading
Strong Fourth Quarter 2024 Results for The Shyft Group, Inc.

Updated Category News Views 91

Shyft Group's Impressive Financial Performance in Q4 2024 The Shyft Group, Inc. (NASDAQ: SHYF) has showcased remarkable financial results for the fourth quarter of 2024, as their operational improvements continue to bolster margins in the Fleet Vehicles and Services (FVS) sector. The company has reported a solid performance driven by enhancements in operational efficiency...

Continue Reading
Smart Plug Market Poised for Massive Growth: 14.52 Billion Outlook

Updated Category News Views 164

Overview of the Smart Plug Market Growth The smart plug market is on an impressive trajectory, expected to soar in value from USD 1.46 billion in 2023 to USD 14.52 billion by 2032, with a remarkable compound annual growth rate (CAGR) of 29.03%. This growth is heavily influenced by the increasing adoption of smart home technologies, as more consumers seek to integrate...

Continue Reading
O'Shaughnessy Ventures Boosts Unseen Japanese Artistry

Updated Category News Views 29

Opening New Doors for Lesser-Known Gem In the world of art investments, where the buzz often centers around bold ideas in flashy markets, O'Shaughnessy Ventures LLC is taking a decidedly different approach. They're backing Kendric Tonn, a quirky and driven painter from Columbus, Ohio, who's on a mission to capture the less traveled, yet visually enchanting nooks of Japan....

Continue Reading
Riot's Rising Bitcoin Production in September 2024

Updated Category News Views 107

Riot's Bitcoin Production Milestone Riot Platforms, Inc. ('Riot' or 'the Company'), an industry leader in Bitcoin mining, has reported an impressive production of 412 Bitcoins in September 2024. This achievement comes as part of the company’s strategy to enhance its capabilities and efficiency in the competitive world of cryptocurrency mining. Operational Highlights...

Continue Reading